Chemerin15-Ameliorated Cardiac Ischemia-Reperfusion Injury is Associated with the Induction of Alternatively Activated Macrophages

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Chang, Chao ^a   Ji, Qingwei ^a   Wu, Bangwei ^b   Yu, Kunwu ^b   Zeng, Qiutang ^b   Xin, Shuanli ^c   Liu, Jixiang ^c   Zhou, Yujie ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c Handan City First Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CARDIOVASCULAR AGENT; CHEMERIN; CHEMERIN15; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; PROTECTIVE AGENT; REACTIVE OXYGEN METABOLITE; TROPONIN T; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CHEMERIN15 PEPTIDE, MOUSE; CHEMOTACTIC FACTOR; PEPTIDE FRAGMENT; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL POLARITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DRUG EFFICACY; EXPERIMENTAL MYOCARDIAL ISCHEMIA; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE REPERFUSION; INFLAMMATION; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REPEATED DRUG DOSE; REPERFUSION INJURY; ANIMAL; C57BL MOUSE; CARDIAC MUSCLE CELL; DRUG EFFECTS; MYOCARDIAL REPERFUSION INJURY;

MUS;

ANIMALS; APOPTOSIS; CHEMOTACTIC FACTORS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; NEUTROPHIL INFILTRATION; PEPTIDE FRAGMENTS;

EID: 84934344123     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/563951     Document Type: Article

References (45)

1. N. G. Frangogiannis, C. W. Smith, and M. L. Entman, "The inflammatory response in myocardial infarction", Cardiovascular Research, vol. 53, no. 1, pp. 31-47, 2002.
2. M. Y. Zuidema and C. Zhang, "Ischemia/reperfusion injury: the role of immune cells", World Journal of Cardiology, vol. 2, no. 10, pp. 325-332, 2010.
3. K. A. Kaminski, T. A. Bonda, J. Korecki, and W. J. Musial, "Oxidative stress and neutrophil activation-the two keystones of ischemia/reperfusion injury", International Journal of Cardiology, vol. 86, no. 1, pp. 41-59, 2002.
4. D. M. Yellon and D. J. Hausenloy, "Myocardial reperfusion injury", The New England Journal of Medicine, vol. 357, no. 11, pp. 1121-1135, 2007.
5. S. Steffens, F. Montecucco, and F. Mach, "The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury", Thrombosis and Haemostasis, vol. 102, no. 2, pp. 240-247, 2009.
6. J. M. Lambert, E. F. Lopez, and M. L. Lindsey, "Macrophage roles following myocardial infarction", International Journal of Cardiology, vol. 130, no. 2, pp. 147-158, 2008.
7. L. Formigli, L. I. Manneschi, C. Nediani et al., "Aremacrophages involved in early myocardial reperfusion injury?" Annals of Thoracic Surgery, vol. 71, no. 5, pp. 1596-1602, 2001.
8. M. Nahrendorf and F. K. Swirski, "Monocyte and macrophage heterogeneity in the heart", Circulation Research, vol. 112, no. 12, pp. 1624-1633, 2013.
9. A. Mantovani, A. Sica, and M. Locati, "Macrophagepolarization comes of age", Immunity, vol. 23, no. 4, pp. 344-346, 2005.
10. L. Cassetta, E. Cassol, and G. Poli, "Macrophage polarization in health and disease", The ScientificWorldJOURNAL, vol. 11, pp. 2391-2402, 2011.
11. S. Gordon and F. O. Martinez, "Alternative activation of macrophages: mechanism and functions", Immunity, vol. 32, no. 5, pp. 593-604, 2010.
12. F. Geissmann, S. Gordon, D. A. Hume, A. M. Mowat, and G. J. Randolph, "Unravelling mononuclear phagocyte heterogeneity", Nature Reviews Immunology, vol. 10, no. 6, pp. 453-460, 2010.
13. J. A. Van Ginderachter, K. Movahedi, G. Hassanzadeh Ghassabeh et al., "Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion", Immunobiology, vol. 211, no. 6-8, pp. 487-501, 2006.
14. V. Dayan, G. Yannarelli, F. Billia et al., "Mesenchymal stromal cells mediate a switch to alternatively activated monocytes/macrophages after acute myocardial infarction", Basic Research in Cardiology, vol. 106, no. 6, pp. 1299-1310, 2011.
15. K. B. Goralski, T. C. McCarthy, E. A. Hanniman et al., "Chemerin, a novel adipokine that regulates adipogenesis and adipocytemetabolism", The Journal of Biological Chemistry, vol. 282, no. 38, pp. 28175-28188, 2007.
16. S. Luangsay, V. Wittamer, B. Bondue et al., "Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model", Journal of Immunology, vol. 183, no. 10, pp. 6489-6499, 2009.
17. S. Parolini, A. Santoro, E. Marcenaro et al., "The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues", Blood, vol. 109, no. 9, pp. 3625-3632, 2007.
18. J. L. Rourke, H. J. Dranse, and C. J. Sinal, "Towards an integrative approach to understanding the role of chemerin in human health and disease", Obesity Reviews, vol. 14, no. 3, pp. 245-262, 2013.
19. K. L. Graham, B. A. Zabel, S. Loghavi et al., "Chemokinelike receptor-1 expression by central nervous system-infiltrating leukocytes and involvement in a model of autoimmune demyelinating disease", Journal of Immunology, vol. 183, no. 10, pp. 6717-6723, 2009.
20. M. Kukla, K. Zwirska-Korczala, A. Gabriel et al., "Chemerin, vaspin and insulin resistance in chronic hepatitis C", Journal of Viral Hepatitis, vol. 17, no. 9, pp. 661-667, 2010.
21. J. Tomalka-Kochanowska, B. Baranowska, E. Wolinska-Witort et al., "Plasma chemerin levels in patients with multiple sclerosis", Neuroendocrinology Letters, vol. 35, pp. 218-223, 2014.
22. Q. Ji, Y. Lin, Z. Liang et al., "Chemerin is a novel biomarker of acute coronary syndrome but not of stable angina pectoris", Cardiovascular Diabetology, vol. 13, Article 145, 2014.
23. X.-Y. Du and L. L. K. Leung, "Proteolytic regulatorymechanism of chemerin bioactivity", Acta Biochimica et Biophysica Sinica, vol. 41, no. 12, pp. 973-979, 2009.
24. V. Wittamer, B. Bondue, A. Guillabert, G. Vassart, M. Parmentier, and D. Communi, "Neutrophil-mediated maturation of chemerin: a link between innate and adaptive immunity", Journal of Immunology, vol. 175, no. 1, pp. 487-493, 2005.
25. J. L. Cash, R. Hart, A. Russ et al., "Synthetic chemerin-derived peptides suppress inflammation through ChemR23", Journal of Experimental Medicine, vol. 205, no. 4, pp. 767-775, 2008.
26. J. L. Cash, M. D. Bass, J. Campbell, M. Barnes, P. Kubes, and P. Martin, "Resolution mediator chemerin15 reprograms the wound microenvironment to promote repair and reduce scarring", Current Biology, vol. 24, no. 12, pp. 1406-1414, 2014.
27. J. L. Cash, S. Bena, S. E. Headland, S. McArthur, V. Brancaleone, and M. Perretti, "Chemerin15 inhibits neutrophil-mediated vascular inflammation and myocardial ischemia-reperfusion injury through ChemR23", EMBO Reports, vol. 14, no. 11, pp. 999-1007, 2013.
28. X. Yan, A. Anzai, Y. Katsumata et al., "Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction", Journal of Molecular and Cellular Cardiology, vol. 62, pp. 24-35, 2013.
29. B. Wu, K. Meng, Q. Ji et al., "Interleukin-37 ameliorates myocardial ischaemia/reperfusion injury in mice", Clinical and Experimental Immunology, vol. 176, no. 3, pp. 438-451, 2014.
30. S. Matsushima, J. Kuroda, T. Ago et al., "Broad suppression of NADPH oxidase activity exacerbates ischemia/reperfusion injury through inadvertent downregulation of hypoxia-inducible factor-1α and upregulation of peroxisome proliferatoractivated receptor-α", Circulation Research, vol. 112, no. 8, pp. 1135-1149, 2013.
31. H. Fliss and D. Gattinger, "Apoptosis in ischemic and reperfused rat myocardium", Circulation Research, vol. 79, no. 5, pp. 949-956, 1996.
32. B. A. Zabel, S. Nakae, L. Zúñiga et al., "Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis", The Journal of Experimental Medicine, vol. 205, no. 10, pp. 2207-2220, 2008.
33. K. E. De Greef, D. K. Ysebaert, M. Ghielli et al., "Neutrophils and acute ischemia-reperfusion injury", Journal of Nephrology, vol. 11, no. 3, pp. 110-122, 1998.
34. J. L. Cash, A. R. Christian, and D. R. Greaves, "Chemerin peptides promote phagocytosis in a ChemR23- and Syk-dependent manner", Journal of Immunology, vol. 184, no. 9, pp. 5315-5324, 2010.
35. F. O. Martinez, A. Sica, A. Mantovani, and M. Locati, "Macrophage activation and polarization", Frontiers in Bioscience, vol. 13, no. 2, pp. 453-461, 2008.
36. L. P. Erwig and P. M. Henson, "Immunological consequences of apoptotic cell phagocytosis", American Journal of Pathology, vol. 171, no. 1, pp. 2-8, 2007.
37. R. E. Voll, M. Herrmann, E. A. Roth, C. Stach, J. R. Kalden, and I. Girkontaite, "Immunosuppressive effects of apoptotic cells", Nature, vol. 390, no. 6658, pp. 350-351, 1997.
38. M. R. Elliott and K. S. Ravichandran, "Clearance of apoptotic cells: implications in health and disease", Journal of Cell Biology, vol. 189, no. 7, pp. 1059-1070, 2010.
39. L. E. M͡oz, K. Lauber, M. Schiller, A. A. Manfredi, and M. Herrmann, "The role of defective clearance of apoptotic cells in systemic autoimmunity", Nature Reviews Rheumatology, vol. 6, no. 5, pp. 280-289, 2010.
40. Y. Takemura, N. Ouchi, R. Shibata et al., "Adiponectin modulates inflammatory reactions via calreticulin receptordependent clearance of early apoptotic bodies", Journal of Clinical Investigation, vol. 117, no. 2, pp. 375-386, 2007.
41. F. Lovren, Y. Pan, A. Quan et al., "Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages", The American Journal of Physiology: Heart and Circulatory Physiology, vol. 299, no. 3, pp. H656-H663, 2010.
42. F. Y. McWhorter, T. Wang, P. Nguyen, T. Chung, and W. F. Liu, "Modulation of macrophage phenotype by cell shape", Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 43, pp. 17253-17258, 2013.
43. M. Arita, F. Bianchini, J. Aliberti et al., "Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1", Journal of Experimental Medicine, vol. 201, no. 5, pp. 713-722, 2005.
44. M. Arita, T. Ohira, Y. P. Sun, S. Elangovan, N. Chiang, and C. N. Serhan, "Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation", Journal of Immunology, vol. 178, no. 6, pp. 3912-3917, 2007.
45. M. Arita, M. Yoshida, S. Hong et al., "Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2, 4, 6-trinitrobenzene sulfonic acidinduced colitis", Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 21, pp. 7671-7676, 2005.